JMDC FY26 Q1 operating profit rises 17% to JPY 1.82 billion; revenue increases 18% to JPY 12.61 billion

• JMDC posted FY2026 Q1 revenue of JPY 12.61 billion, up 18% year over year, with operating profit rising 17% to JPY 1.82 billion.
• Profit attributable to owners of parent climbed 17% to JPY 1.13 billion; EBITDA increased 17% to JPY 2.66 billion, keeping the margin flat at 21%.
• Healthcare-Big Data revenue rose 19% to JPY 10.96 billion, led by For Industry at JPY 4.59 billion, up 26%.
• Tele-medicine revenue increased 8% to JPY 1.65 billion; EBITDA advanced 22% to JPY 653 million, lifting the margin to 40% from 35%.
• Management flagged stronger-than-expected pharmaceutical demand, a 26% year-over-year rebound in medical-department transaction volume, and about JPY 400 million of Q2 revenue pulled into Q1.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JMDC Inc. published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.